Peptides Factory Direct See pricing & order
Home / Reference / NAD+
Longevity / Mitochondrial - IV / IM / SC

NAD+ Research Reference

NAD+ is a central metabolic cofactor involved in mitochondrial respiration, ATP production, redox balance, sirtuin/PARP-linked signaling, and cellular energy transfer.

Research reference only. This is an educational, mechanism-level reference for an investigational research compound - not medical advice, a prescription, or a protocol to follow. Reconstitution, dosing, and pharmacokinetic figures are research-reference values for laboratory context only. Products are research-use-only, not for human or animal consumption, and not FDA approved. Confirm all concentration math and review with a qualified clinician before any formal research use.
See live pricing, stock & bundles for NAD+

Create a free research account to view current pricing and place an order.

See live pricing & order →

Mechanism of action

NAD+ is a central metabolic cofactor involved in mitochondrial respiration, ATP production, redox balance, sirtuin/PARP-linked signaling, and cellular energy transfer.

Half-life & pharmacokinetics

Half-life: Rapid systemic utilization.

NAD+ is rapidly utilized in cellular redox systems. Tolerability is highly rate- and route-dependent, especially with larger exposures.

Research dosing reference

250-1000 mg weekly or divided administration protocols depending on route and tolerance.

Dose interpretation (U-100 units)

Target doseU-100 units
250 mg300 units
500 mg600 units
1000 mg1200 units

Units are concentration-specific - confirm against your actual reconstitution volume.

Reconstitution & concentration

VialPreferred reconstitutionFinal concentration
500 mg6 mL BAC Water preferred for 500 mg0.833 mg/unit
1000 mg10 mL BAC Water1.000 mg/unit

Injection timing

Often administered earlier in the day due to energy/metabolic effects. Large exposures should be slow and tolerance-aware.

Beginner escalation

Escalate gradually; aggressive administration can create strong flushing, pressure, nausea, or fatigue sensations.

Side-effect mitigation

Monitor flushing, nausea, chest tightness, fatigue, warmth, lightheadedness, or injection discomfort.

Stack compatibility

Often paired conceptually with SS-31, MOTS-C, NAD+, glutathione, or metabolic protocols, using conservative sequencing for interpretability.

Storage & stability

Refrigerated after reconstitution; protect from heat/light. Administration route and concentration strongly affect comfort.

Protocol duration & reassessment

Mitochondrial protocols often run 4-12 weeks, followed by reassessment of fatigue, exercise tolerance, recovery, sleep, and energy consistency before continuing or repeating.

Frequently asked questions

What is NAD+ and how does it work?

NAD+ is a central metabolic cofactor involved in mitochondrial respiration, ATP production, redox balance, sirtuin/PARP-linked signaling, and cellular energy transfer.

What is the half-life of NAD+?

NAD+: Rapid systemic utilization. NAD+ is rapidly utilized in cellular redox systems. Tolerability is highly rate- and route-dependent, especially with larger exposures.

How is NAD+ reconstituted for research?

Preferred reconstitution for the 500 mg vial is 6 mL BAC Water preferred for 500 mg, giving 0.833 mg/unit. Always confirm concentration math before any use. Research use only.

Is NAD+ FDA approved?

No. NAD+ is an investigational research-use-only compound - not for human or animal consumption and not FDA approved.

All research reference · Research guides

External references: Peptide (Wikipedia) · U.S. Food and Drug Administration

NAD+ is an investigational research-use-only compound, not for human or animal consumption, not FDA approved, and not intended to diagnose, treat, cure, or prevent disease. This reference is not medical advice.